Journal article · 2013

Abstract C245: Discovery and characterization of a new Wnt/β-catenin pathway inhibitor targeting tankyrase.

Ryoko Okada, Yuichi Takahashi, Yasuo Watanabe, Hiroshi Ishida, Junichi Saito, Ryuichiro Nakai

Molecular Cancer Therapeutics, 12(11_Supplement), C245 · Published 1 November 2013 · DOI 10.1158/1535-7163.targ-13-c245

View at the publisherCite this paper

In brief

“Abstract C245: Discovery and characterization of a new Wnt/β-catenin pathway inhibitor targeting tankyrase.” is a 2013 journal article by Ryoko Okada and 5 co-authors, published in Molecular Cancer Therapeutics. OpenAlex counts 0 citations as of 21 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
0
Authors
6

Abstract

Background: Wnt/β-catenin pathway controls many biological processes including cell proliferation and tissue development. In Wnt pathway, β-catenin is a key downstream factor which interacts with transcription factor T-cell factor (TCF) in the nucleus and induces expression of TCF responsive genes. β-catenin degradation is promoted by a cytoplasmic complex of APC, Axin and Gsk3β. In many… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Okada, R., Takahashi, Y., Watanabe, Y., Ishida, H., Saito, J., & Nakai, R. (2013). Abstract C245: Discovery and characterization of a new Wnt/β-catenin pathway inhibitor targeting tankyrase. Molecular Cancer Therapeutics, 12(11_Supplement), C245. https://doi.org/10.1158/1535-7163.targ-13-c245

MLA 9

Okada, Ryoko, et al. “Abstract C245: Discovery and characterization of a new Wnt/β-catenin pathway inhibitor targeting tankyrase.” Molecular Cancer Therapeutics, vol. 12, no. 11_Supplement, 2013, p. C245. https://doi.org/10.1158/1535-7163.targ-13-c245.

Chicago

Okada, Ryoko, Yuichi Takahashi, Yasuo Watanabe, Hiroshi Ishida, Junichi Saito, and Ryuichiro Nakai. 2013. “Abstract C245: Discovery and characterization of a new Wnt/β-catenin pathway inhibitor targeting tankyrase.” Molecular Cancer Therapeutics 12 (11_Supplement): C245. https://doi.org/10.1158/1535-7163.targ-13-c245.

Harvard

Okada, R. et al. (2013) ‘Abstract C245: Discovery and characterization of a new Wnt/β-catenin pathway inhibitor targeting tankyrase.’, Molecular Cancer Therapeutics, 12(11_Supplement), p. C245. doi:10.1158/1535-7163.targ-13-c245.

IEEE

R. Okada, Y. Takahashi, Y. Watanabe, H. Ishida, J. Saito, and R. Nakai, “Abstract C245: Discovery and characterization of a new Wnt/β-catenin pathway inhibitor targeting tankyrase.,” Molecular Cancer Therapeutics, vol. 12, no. 11_Supplement, p. C245, 2013, doi: 10.1158/1535-7163.targ-13-c245.

BibTeX

@article{okada2013abstract,
  title     = {{Abstract C245: Discovery and characterization of a new Wnt/β-catenin pathway inhibitor targeting tankyrase.}},
  author    = {Okada, Ryoko and Takahashi, Yuichi and Watanabe, Yasuo and Ishida, Hiroshi and Saito, Junichi and Nakai, Ryuichiro},
  journal   = {Molecular Cancer Therapeutics},
  year      = {2013},
  volume    = {12},
  number    = {11_Supplement},
  pages     = {C245},
  doi       = {10.1158/1535-7163.targ-13-c245},
  url       = {https://doi.org/10.1158/1535-7163.targ-13-c245}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer

  • tankyrase
  • tankyrase 1
  • TNKS2
  • AXIN1
  • Axin2
  • β-catenin degradation
  • co-crystal structure
  • colon cancer

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Okada, R., Takahashi, Y., Watanabe, Y., Ishida, H., Saito, J., & Nakai, R. (2013). Abstract C245: Discovery and characterization of a new Wnt/β-catenin pathway inhibitor targeting tankyrase. Molecular Cancer Therapeutics, 12(11_Supplement), C245. https://doi.org/10.1158/1535-7163.targ-13-c245

How many times has this paper been cited?

0 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Ryoko Okada, Yuichi Takahashi, Yasuo Watanabe, Hiroshi Ishida, Junichi Saito, Ryuichiro Nakai.

What is the DOI of this paper?

10.1158/1535-7163.targ-13-c245, permanently at https://doi.org/10.1158/1535-7163.targ-13-c245. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.